Literature DB >> 2072218

Verotoxic Escherichia coli in human disease.

J N Rosensweig1, G R Gourley.   

Abstract

Verotoxin-producing E. coli (most frequently E. coli O157) have been implicated in the pathogenesis of diarrhea, hemorrhagic colitis, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Cattle, meat products, and other sources have been found to harbor these organisms. Isolation of E. coli O157:H7 on MacConkey-sorbitol agar is diagnostic, yet the bacteria are difficult to detect after the first week of infection. Enzyme linked immunosorbent assays (ELISAs) can detect verotoxin in fecal filtrates in the absence of viable bacteria. Serologic evidence has also been used to support the diagnosis of verotoxin-associated infection. Evidence supporting the etiologic role of different verotoxins is reviewed. Treatment remains supportive since the use of antibiotics and antimotility agents can lead to poorer outcomes. Recommendations for prevention are presented.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2072218     DOI: 10.1097/00005176-199104000-00001

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

Review 1.  Colonic stricture secondary to hemolytic uremic syndrome caused by Escherichia coli O-157.

Authors:  Kouji Masumoto; Yuko Nishimoto; Tomoaki Taguchi; Yasushi Tsutsumi; Satomi Kanemitsu; Toshiro Hara; Sachiyo Suita
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

2.  Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production.

Authors:  J M Klapproth; M S Donnenberg; J M Abraham; H L Mobley; S P James
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

3.  Successful Colectomy for Hemorrhagic Colitis with Hemolytic Uremic Syndrome and Acute Encephalopathy due to Escherichia coli O157 Infection.

Authors:  Tetsuro Tominaga; Masahiro Oikawa; Hiroaki Takeshita; Masaki Kunizaki; Kazuo Tou; Takafumi Abo; Shigekazu Hidaka; Atsushi Nanashima; Terumitsu Sawai; Takeshi Nagayasu
Journal:  Case Rep Gastroenterol       Date:  2014-03-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.